Comparison of the Performance Between Conventional Colonoscopy and 3D Colonoscopy in Positive Fecal Immunochemical Test Group

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Nov 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a new type of colonoscopy called 3D colonoscopy compared to the standard 2D colonoscopy. The goal is to see if 3D colonoscopy can better detect pre-cancerous growths (adenomas) in people who have tested positive on a fecal immunochemical test (FIT). Detecting these adenomas is important because they can help prevent colorectal cancer. This study is particularly focused on finding flat or depressed lesions that might be missed by traditional methods, which can be a concern for patients with a positive FIT.

To participate in this trial, individuals must be at least 40 years old and have received a positive result on their fecal immunochemical test. Those who have certain medical conditions or previous surgeries that affect the colon may not be eligible. Participants can expect to undergo a colonoscopy using either the standard or the new 3D technique, and their results will help researchers understand if the 3D method is more effective in detecting potential cancer risks. The trial is currently recruiting participants, and it aims to contribute valuable information to improve colon cancer prevention strategies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects who are 40 years of older
• • Subjects who have positive fecal immunochemical test
• Exclusion Criteria:
• • Contraindication for colonoscopy
• • Subjects with familiar or hereditary polyposis
• • Subjects with history of colectomy
• • Inadequate bowel cleansing level
• • Subjects with inflammatory bowel disease